Endeavor

Expanding Patient Care Through Moffitt at SouthShore

New outpatient campus brings treatment and clinical trials closer to home

Is Immunotherapy Before and After Surgery a Better Strategy for Certain Cancers?

Several studies from the ASCO Annual Meeting suggest earlier use of immunotherapy improves survival for colon, head and neck and stomach cancers

Can Triplet Therapy Help Treat Symptomatic Melanoma Brain Metastases?

Targeted therapy combined with immunotherapy gave patients longer progression-free survival and higher response rates, study says

New Drug Duo Significantly Slows Progression of Aggressive Breast Cancer

Phase 3 trial shows sacituzumab govitecan and pembrolizumab outperform standard treatment in triple-negative breast cancer

New Drug Significantly Improves Outcomes for Patients with Polycythemia Vera

The therapy reduces the need for the therapeutic removal of blood and improves symptoms

From Diagnosis to Advocacy: Melanoma Survivor Shows Why Clinical Trials Matter

Mary Margaret Braddock credits research, clinical trials and dedicated care teams for saving her life and giving others hope

Reaching for the Stars

CAR T therapy transformed one man’s battle with cancer into a story of survival, discovery and impact

Can AI Help Get Clearer Margins During Breast Surgery?

New imagining system identified residual cancer in 40% of patients

New Immunotherapy Strategy Improves Outcomes in Patients with Advanced Head and Neck Cancer

Patients treated with pembrolizumab were at least 27% less likely to experience cancer recurrence or death